Naloxone Accord (Naloxone)

Naloxone is an opioid antagonist used in the management of opioid‑related emergencies.

• Opioid overdose: rapid reversal of life‑threatening respiratory depression and sedation.
• Opioid‑induced respiratory depression: restores adequate breathing in patients receiving opioid analgesia.
• Peri‑operative opioid toxicity: counteracts excessive opioid effects during anesthesia or procedural sedation.

• Naloxone acts as a competitive antagonist at μ‑opioid receptors and, to a lesser extent, at κ‑ and δ‑opioid receptors. By displacing opioid agonists from these sites, it rapidly reverses opioid‑mediated inhibition of the brainstem respiratory centers, restoring normal respiratory drive and consciousness without producing analgesia.

Naloxone is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Vomiting: occasional emesis following administration.
• Sweating: increased diaphoresis during reversal.
• Agitation or anxiety: transient nervousness.

Serious or Rare Side Effects

• Severe hypertension: sudden rise in blood pressure.
• Cardiac arrhythmia: irregular heart rhythm.
• Pulmonary edema: fluid accumulation in the lungs.
• Anaphylaxis: rare severe allergic reaction requiring immediate medical attention.

Naloxone should be used with careful clinical assessment and monitoring.

• Airway assessment: ensure the patient’s airway is protected before administration.
• Vital sign monitoring: observe blood pressure, heart rate and oxygen saturation after dosing.
• Indication verification: give only when opioid overdose or toxicity is suspected.
• Cardiovascular caution: use cautiously in patients with known heart disease or hypertension.
• Hypersensitivity check: avoid in individuals with documented allergy to naloxone or formulation components.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Naloxone may interact with other agents that affect the central nervous system or cardiovascular function.

Major Interactions (Avoid)

• Buprenorphine or mixed agonist‑antagonist opioids: can precipitate severe withdrawal.
• High‑potency opioids (e.g., fentanyl): may require repeated dosing, complicating management.
• Vasopressors: concurrent use may mask hypotensive effects of naloxone.

Moderate Interactions (Monitor Closely)

• Opioid agonists (e.g., morphine, oxycodone): may need dose adjustment after naloxone reversal.
• Benzodiazepines: can obscure signs of opioid reversal and respiratory status.
• Tricyclic antidepressants: may increase seizure risk when combined with rapid opioid antagonism.